chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This 51-year-old female was vaccinated with Vivotif (Batch no.: unknown) on 15.Jan.2006. Concomitantly she received yellow fever vaccine, DT vaccine, IPV and hepatitis A vaccine. Two days later, on 17.Jan.2006 the patient developed RED RAISED SPOTS ON TRUNK AND LEGS. She continued vaccination (Vivotif) and after the 4th dose on 21.01.2006 she noticed that the spots had covered had covered her body with the exception of her face. The patient contacted the physician on 24.01.2006 when she started that the rash had lessened. The patient had no fever, hives or breathing difficulty. Outcome of reaction: recovery. Treatment of reaction: not reported. This case was reported. The case was reported to be non-serious.
Rash on skin of neck, chin, and near L ear, not on rest of body; onset not known; described as itchy; photographs seen by SHD show a non-descript, patchy red rash, slightly raised; treated with Benadryl.  Patient takes daily vitamins and hormone pills.
Muscle pains all throughout my body, paint in joints, pain in lower back and a slight fever of 99.8.
extreme chills and fever took aspirin Rested fever went down within five to six hours.      Fever was 102at the onset
Woke up Christmas day with a sore throat. I tested positive with an at home COVID-19 test, positive on 12/27. Called in prescription for PAXLOVID. Within a day or so, I was really congested and very tired. Axillary and posterior cervical lymph nodes swollen. Fever peaked at 101, with a little headache and body aches for a couple of days. Slight rebound of symptoms after PAXLOVID. Felt better on 1/6/2023.
towards end of monitoring time post vaccine, c/o feeling shaky, having visual disturbances, nausea, and headache. brought back to obs 1722, 1724 bp 134/78 hr 71 rr 18 sao2 99% on ra. patient laying on stretcher, feeling relief of headache, flushing, and lightheadedness, but headache remains, though improved. 1730 bp 120/81 hr 73 rr 18 sao2 99% on ra, s/s improved, head pressure relieving, and visual disturbances improved. patient sitting up on side of bed at 1745 bp 124/75 hr 75 rr 20 sao2 99% on ra, denies increased s/s with standing. agrees stable to be escorted to personal vehicle, no further issues
"Received shot around 2pm, by 5pm was experiencing chills/shaking. Temperature 100.8. Took Tylenol, but fever persisted throughout the night reaching 101.4 at the highest. Had headache and restless night. Could not work the next day due to fevers and not sleeping."
Sun, 5-2-21, Petechiae appears on my lower feet, ankles, and lower legs/shins.  Random bruises appearing without contact/bump. Mon, 5-3-21, Petechiae now appearing on my hands, forearms.  Petechiae spots beginning to appear on my face.  Nose and mouth bleeding.  Went to hospital ER on  5-3-21. Rec'd IGIV  (2 days), and Decadron (Steroid) 40mg daily (5 days).   Discharged from Hospital after 5 days on 5-7-21, with platelet count at 58 (58,000). - Follow-up blood draw post-discharge on 5-13-21 showed platelet level back down to 1 (1,000).  Directed to hospital by hematologist office, re-admitted on 5-13-21.   Rec'd IGIV (3 days) and IV Solumedrol (Steroid), and Oral Steroid (2 days).   Discharged again from Hospital after 2nd 5-day hospital stay.
Arm started tingling; Arm became numb; Soreness in arm; Rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Arm started tingling), HYPOAESTHESIA (Arm became numb), PAIN IN EXTREMITY (Soreness in arm) and VACCINATION SITE RASH (Rash at injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Cardiac disorder NOS. Concomitant products included IBUPROFEN for Arthritis.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PARAESTHESIA (Arm started tingling), HYPOAESTHESIA (Arm became numb), PAIN IN EXTREMITY (Soreness in arm) and VACCINATION SITE RASH (Rash at injection site). At the time of the report, PARAESTHESIA (Arm started tingling), HYPOAESTHESIA (Arm became numb), PAIN IN EXTREMITY (Soreness in arm) and VACCINATION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that she took ibuprofen which she was already taking for arthritis.   This case was linked to MOD-2021-044537 (Patient Link).
2:30pm Received 1st dose of Moderna. Hx of SOB/swelling with allergy shots. 2:45pm c/o itching around lips. VS BP 166/19 P 90 o2 sat 97% RA, alert, ambulatory. 2:50pm Benadryl 50 mg IM stat LGM. 2:55pm BP 171/71 P 90 O2 sat 98% RA, reports itching resolved. 3:00pm BP 147/88 P 87 O2 sat 97% RA. 3:15pm ambulatory, but became unsteady, sat in chair. 3:19pm BP 153/75 P 77 3:24pm BP 148/78 P 80 3:25pm ambulatory to truck. 3:28pm husband returned to clinic to report wife's rash. Instructed to go to ER. Report called to ER. 01/21/21. F/U call. Pt reports observed in ER, no treatment. Instructed to take Benadryl 50 mg po bid x 2 days.  No further problems.
After receiving my booster shot of the COVID-19 vaccine; my lymph node swelled up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administered in arm (Lot number: FH8027) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 01), for Covid-19 immunization; Bnt162b2 (Dose: 02), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "After receiving my booster shot of the COVID-19 vaccine"; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "my lymph node swelled up".  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 30-SEP-2013 the patient was vaccinated with M-M-R II (reported batch # H018950 corresponding with lot # 1483AA; expiration date 18-OCT-2014). The vaccine was exposed to temperature exposures for 50F for 85 minutes, 47F for 15 minutes, 48F for 35 minutes, 52 F for 95 minutes, 48F for 30 minutes on 20-SEP-2013 and 48F for 45 minutes on 25-SEP-2013. No known adverse effects. This case is linked to case 1310USA001610, 1310USA008360, 1310USA008361, 1310USA008362, 1310USA008363, 1310USA008364, 1310USA008365, 1310USA008366, 1310USA008367, 1310USA008368, 1310USA008369, 1310USA008370, 1310USA008371, 1310USA008372, 1310USA008373, 1310USA008374, 1310USA008375, 1310USA008376, 1310USA008377, 1310USA008378, 1310USA008379, 1310USA008380, 1310USA008381, 1310USA008382, 1310USA008383, 1310USA008384, 1310USA008385, 1310USA008386, 1310USA008387, 1310USA008388, 1310USA008389, 1310USA008390, 1310USA008391, 1310USA008392, 1310USA008393, 1310USA008394, 1310USA008395, 1310USA008396, 1310USA008397, 1310USA008398, 1310USA008399, 1310USA008400, 1310USA008401, 1310USA008403, 1310USA008404, 1310USA008405, 1310USA008406 and 1310USA008407 (same reporter link). Additional information has been requested.
Became faint lasting 5 seconds. Airway opened, upon becoming more alert, juice given, observed x 10 minutes, discharged ambulatory with parent.
Left arm from elbow to shoulder red, hot and indurated. Dr advised Benadryl 50mg every 6 hours prn and Aleve as an antiinflammatory prn. Pt was instructed to report back to office or Dr (phone # provided). To go to ER if any other severe reaction occurs, e.g. SOB. Still red at injection site. To see MD this afternoon.
Adverse drug reactions (including pain) after human papillomavirus (HPV) vaccine; Adverse drug reactions (including pain) after human papillomavirus (HPV) vaccine; product origin unk; This spontaneous social media report was received from an other health professional and refers to a female patients in age between 12 to 24 years old. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the patient was vaccinated with human papillomavirus (HPV) vaccine (manufacturer unknown) (dose, route of administration, lot #, expiration date were not reported) for prophylaxis. On unknown day, the patient experienced undesirable drug effects (including pain). The outcomes of the events were not reported.  The events were considered as related to human papillomavirus (HPV) vaccine (manufacturer unknown).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2107USA001853: US-009507513-2107USA008730: US-009507513-2107USA008731: US-009507513-2107USA008732: US-009507513-2107USA008729: US-009507513-2107USA008733: US-009507513-2107USA008727:
Wednesday 1/17/2018: Legs felt "weird" and tingly. Thursday 1/18/2018: Tingling in the hands, hands "falling asleep".
Three weeks ago, I was diagnosed with COVID-19. I was experiencing a fever over 101, aching joints and muscles, coughing, fatigue and eventually lost my sense of taste and smell. I received an infusion a few days after testing positive. As of today, I am still coughing.
24 hours after vaccine, I had some raised welps and hives pop up on lower back but I did not attribute them to the vaccine until after my 2nd dose.
hives on both arms; This spontaneous case was reported by a patient family member or friend and describes the occurrence of URTICARIA (hives on both arms) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concomitant products included ALLOPURINOL, SIMVASTATIN, DONEPEZIL, CYANOCOBALAMIN (B12 [CYANOCOBALAMIN]) and MELATONIN for an unknown indication.  On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced URTICARIA (hives on both arms). At the time of the report, URTICARIA (hives on both arms) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient took Benadryl (diphenhydramine).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up was received on 20 Apr 2021 included no additional information.
Case number PHEH2013US018713, is an initial spontaneous report received from a nurse on 04 SEP 2013. This case refers to a male patient of unspecified age. Past medical history and concomitant medication were not reported. He was vaccinated with MENVEO (batch number: A11032) at dose of 0.5 ml intramuscularly on 30 JUL 2013, MENVEO had experienced a one time temperature excursion of 9.0-9.5 C for maximum time of 18 minutes. No adverse event was reported following this administration error.
Migraines with nausea, vomiting, and photosensitivity, at least two-three days/week causing this writer to miss work. Treats migraines with fioricet, Tylenol, and ice packs. Migraines are 8/10 sharp, throbbing  pain on top/front of scalp that radiates down to forehead and right and left side of scalp.  Pain begins upon waking in morning and is sometimes relieved by fioricet, other times migraines will go unrelieved for up to two days.
I had 2 shots for shingles and got them anyway/ suspected vaccination failure; I had 2 shots for shingles and got them anyway; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The patient had 2 shots for shingles and got them anyway. This case was considered as suspected vaccination failure as details regarding time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
Sever headache, nausea, muscle ache, abdominal cramps, fatigue
12/7 - In ER with chest pain. Patient was tachypnic O2 sat 94% RA, desat to 80s ambulating. RR 33, HR101. WBC 30.1, D dimer 270. Temp WNL. Covid + with CXR showing bibasilar patchy infiltrates. CT showed no PE, airspace opacities mostly groundglass. Admitted for Covid 19/chest pain r/o ACS. Monoclonal A, decadron, Lovenox, fluids given.  12/8 - chest pain resolved. Sat WNL on room air.  12/9 - Discharged 12/10- Returns to ED worsening Covid symptoms-O2 sat in 70s. In 90s on 2LNC. Significant wheezing heard on inspiration and exportation. Treated with O2, Decadron, fluids. Admit to inpatient for Covid pneum. Baricitinib,Doxycycline, Remdisivir ordered. WBC trending down-29.2. Vitals WNL. Lovenox,decadron continued.
i skipped my period, my period is usually very regular and i missed an entire cycle. currently having a very intense, heavy, and cramp filled period which is irregular
Patient was given PNEUMOVAX 23 on 8/14/17 at approximately 1430. Around 2300 he reports he began having pain at injection site ((L) Deltoid). Denies redness, swelling, fever. Called office to report 8/15/17 at 10:00. Ice, APAP, Ibuprofen per PCP.
Red mark at injection site; Itchy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red mark at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Red mark at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red mark at injection site) and VACCINATION SITE PRURITUS (Itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator o No treatment medications provided by the reporter.
Information has been received from a 73 year old female patient who was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (lot# was not provided). On 09-APR-2009 the patient developed shingles after getting the vaccine. The patient sought unspecified medical attention. At the time of reporting the patient was not recovered. Lab diagnostic included culture test. Additional information has been requested.
Patient received FLUVIRIN IM right arm 11/18/13. Reported tingling in wrist (right) immediately. Experiencing tingling, pain the length of right arm, right scapular pain, underarm soreness. No rash, redness or fever.
SWELLING AND REDNESS ON UPPER LEFT ARM, VERY HOT AND RED FOR LAST 24 HRS ALL THE WAY TO THE ELBOW, CALLING DOCTOR IN THE MORNING.
Vaccination site began swelling, was warm and tender to touch a few hours after given. By the following day 4/10, the swelling had increased. Pain on putting any pressure in the area happens often, or on raising my arm. This is especially surprising because I take 100mg of Tramadol 3x a day for spine issues. The pain is easily bleeding through that. On 4/10 in the late evening, I noticed the swelling was worse, now sticking out about 1/2 inch and a pink area about the size of a half dollar around the state. Early morning on 4/11 the area started itching, usually mildly but occasionally stronger and very annoying. Scratching it is painful. There is no rash or pustules or blisters.
moderate arm pain; mild myalgia; mild fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46 year-old female patient received bnt162b2 (COMIRNATY), intramuscular, administered in arm right, administration date 15Oct2021 (Lot number: EW0217) at the age of 46 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administered in arm right, administration date 02Oct2021 (Batch/Lot number: unknown) as dose 1, single. Relevant medical history included: "hypothyroidism" (unspecified if ongoing); "GERD" (unspecified if ongoing); "migraine" (unspecified if ongoing); "chronic allergic rhinitis" (unspecified if ongoing). Concomitant medication(s) included: ALAVERT; DYMISTA; LEVOXYL; NEXIUM [ESOMEPRAZOLE MAGNESIUM TRIHYDRATE]; RHINOCORT [BUDESONIDE]. Past drug history included: None. Vaccination history included: Comirnaty (pfizer-biontech covid-19 vaccine) (Dose Number: 2, Batch/Lot No: EP6955, Route of Administration: Intramuscular), administration date: 24Mar2021, when the patient was 45 years old, for COVID-19 immunisation, reaction(s): "arm pain", "myalgia", "fatigue"; Comirnaty (pfizer-biontech covid-19 vaccine) (Dose Number: 1, Batch/Lot No: EL3247), for COVID-19 immunisation, reaction(s): "arm pain". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 15Oct2021 19:00, outcome "recovered" (17Oct2021), described as "moderate arm pain"; MYALGIA (non-serious) with onset 15Oct2021 19:00, outcome "recovered" (16Oct2021), described as "mild myalgia"; FATIGUE (non-serious) with onset 15Oct2021 19:00, outcome "recovered" (16Oct2021), described as "mild fatigue". Therapeutic measures were not taken as a result of pain in extremity, myalgia, fatigue.  Additional information: Patient arm pain was worse than with Dose 1 and Dose 2; all other systemic AEs were mild and less than those following Dose 2. Eligibility for booster dose was based on the underlying medical conditions listed on CDC website and not due to immunosuppression nor occupational exposure.  No follow-up attempts are possible. No further information is expected.
muscle pain; low-grade fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain) and PYREXIA (low-grade fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition were reported.).  No concomitant medication reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (muscle pain) and PYREXIA (low-grade fever). At the time of the report, MYALGIA (muscle pain) and PYREXIA (low-grade fever) outcome was unknown.      No treatment medication was reported.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
About 1 and a half after receiving the vaccine I ate 3 pieces of pizza then about 30 minutes later my heart starting pounding (i could feel my heart beating heavily thru my chest at a steady pace. I would not say my heart was racing but instead a strong pounding.  I walked at a steady pace around my house for about a hour and it finally stopped just as fast as it started.   Also, I mentioned eating before it started so im not sure if that contributed to it.  Sometimes my heart will feel heavy and beat heavy after eating too much but not like this as it was much more intense.  Before the reaction occurred I felt calm and relaxed.  My main concern is:  Should I get my second dose which is due in a week?  Im not sure what to do.
SORENESS IN ARM; VERY TIRED; This spontaneous report received from a consumer concerned a 48 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 04-APR-2021 for prophylactic vaccination. The batch number was not reported. Company is unable to perform follow-up to confirm batch/lot number. No concomitant medications were reported. On 04-APR-2021, the subject experienced very tired. On 06-APR-2021, the subject experienced soreness in arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from soreness in arm, and very tired. This report was non-serious.
Based on patient interview on 30 Jun 2020, the specific timeline of symptom onset following vaccine receipt on 24 May 2019 is "hard to pinpoint". SM does, however, recall experiencing swelling of his left wrist accompanied by a burning sensation on the evening of vaccine receipt, which resolved within 24 hours. He denies associated swelling of his throat/airway, wheezing, and cough, vomiting and diarrhea, and dizziness and loss of consciousness. SM believes he experienced generalized aching, fever, and fatigue within 1-2 days of vaccine receipt. Per Dr. AHLTA entry dated 23 Aug 2019 a 3-month history of "fatigue, joint pain (hands, knees, upper and lower legs), drenching night sweats, lymph node fullness and tenderness in his neck, and a variety of rashes" was reported. Within 1-2 days of resolution of left wrist swelling and discomfort, SM experienced swelling.
30 year old femail received Janssen vaccine Lot# 1808982 exp: 6/23/21 at approximately 3pm in the left deltoid.  Immediately after being vaccinated, pt. requested to remain seated.  The nurse noted that the pt. was getting pale so she suggested the pt. take off the surgical mask to get some air.  Before pt. had a chance to take off the mask she lost consciousness.  Together with another nurse patient was lowered onto the floor.  Pt. regained consciousness for 30-45 seconds and then began to have seizure like activity.  Her eyes rolled back and her body became stiff and began a jerking motion.  911 was called. This seizure like activity lasted 4-6 seconds at which time pt. regained consciousness and immediately sat up.  Pt was pale and diaphoretic.  BP 98/64, HR 78, Pulse Ox 99%.  Pt vomited multiple times.  Ice was applied to the posterior neck and a cold compress to the forehead .  EMS arrived and took vitals: BP 78/40.  Pt. was aware of person, place and situation.  Pt. was taken to Hospital accompanied by her husband.  Pt was called by me Friday and she was home.  All tests showed no sign of having a seizure.
At site of ZOSTAVAX injection LUE erythema and induration 4.5 x 5.5 cm.